Presentation is loading. Please wait.

Presentation is loading. Please wait.

Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis 

Published byAlberta Barber Modified over 5 years ago

Similar presentations

Presentation on theme: "Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis "— Presentation transcript:

1 Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis  Xiao Li, MD, Liyan Wan, MD, Hong Shen, PhD, MD, Jian Geng, MD, Jing Nie, PhD, Guobao Wang, MD, Nan Jia, PhD, MD, Meng Dai, PhD, MD, Xiaoyan Bai, PhD, MD  Journal of Thoracic Oncology  Volume 7, Issue 1, Pages (January 2012) DOI: /JTO.0b013e318232b98a Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Thyroid transcription factor-1 (TTF1) gene amplification in primary lung adenocarcinoma, lymph node metastasis, and malignant pleural effusions detected with nuclei microarray fluorescence in situ hybridization (NMA-FISH). A, Overview of a NMA slide (hematoxylin and eosin [H&E]). B, One NMA disk stained by diamidinophenyl-indole (DAPI, original magnification, ×200). C, TTF1 gene amplification in primary lung adenocarcinoma (63× oil). D, TTF1 gene amplification in lymph node metastasis (63× oil). E, TTF1 gene amplification in MPEs (63× oil). Red signals represent amplification of the NKX2-1 probe and green signals represent a chromosome 14 reference probe. Nuclei are stained in blue with DAPI. Journal of Thoracic Oncology 2012 7, 76-84DOI: ( /JTO.0b013e318232b98a) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Thyroid transcription factor-1 (TTF1) messenger RNA (mRNA) expression level was twofold higher in lung adenocarcinomas with TTF1 gene amplification. A, Quantitative real-time polymerase chain reaction (PCR) showed increased TTF1 mRNA expression level in lung adenocarcinomas with TTF1 gene amplification compared with normal lung and lung adenocarcinomas without TTF1 gene amplification. B, Representative image of mRNA expression level of seven snap-frozen tumor tissues and matched normal lung tissues detected by reverse transcriptase (RT)-PCR. T4, T5, and T6 represented three lung adenocarcinoma tissues with TTF1 gene amplification. Journal of Thoracic Oncology 2012 7, 76-84DOI: ( /JTO.0b013e318232b98a) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Thyroid transcription factor-1 (TTF1) protein and messenger RNA (mRNA) expressions were positive in papillary subtype of primary lung adenocarcinomas and lymph node metastases and negative in invasive mucinous primary lung adenocarcinomas (scale bar: 100μm). A, Positive TTF1 protein expression in papillary lung adenocarcinoma. B, Positive TTF1 mRNA expression in papillary lung adenocarcinoma. C, Negative TTF1 protein expression in invasive mucinous lung adenocarcinoma. D, Negative TTF1 mRNA expression in invasive mucinous lung adenocarcinoma. E, Positive TTF1 protein expression in lymph node metastasis. F, Positive TTF1 mRNA expression in lymph node metastasis. Journal of Thoracic Oncology 2012 7, 76-84DOI: ( /JTO.0b013e318232b98a) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Representative images of thyroid transcription factor-1 (TTF1) protein and messenger RNA (mRNA) expressions in the MPE of patients with lung cancer (scale bar: 100 μm). TTF1 expressions were positive in five cases of MPE (three invasive mucinous types and two papillary types). A-1, Hematoxylin and eosin (H&E); A-2, negative TTF1 protein; and A-3, mRNA expressions in papillary lung adenocarcinoma. B-1, H&E; B-2, positive TTF1 protein; and B-3, mRNA expressions in invasive mucinous lung adenocarcinoma. C, Representative TTF1 expressions in MPE detected by Western blot. Journal of Thoracic Oncology 2012 7, 76-84DOI: ( /JTO.0b013e318232b98a) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

6 FIGURE 5 Kaplan-Meier estimates of overall survival among patients with lung adenocarcinomas according to thyroid transcription factor-1 (TTF1) expressions and TTF1 amplification. A, There was a trend toward a worse overall survival for patients with lung adenocarcinoma with positive TTF1 expressions and TTF1 gene amplification compared with patients with TTF1 expressions and no TTF1 amplification (median: 48.4 versus 74.3 months, p = 0.068). B, The overall survival time was longer for patients with lung adenocarcinoma with positive TTF1 expressions, than for patients with negative TTF1 expressions (median: 72.6 versus 42.5 months, p < 0.001). C, The overall survival time was significantly longer for patients with positive TTF1 expressions in MPE compared with patients with negative TTF1 expressions (median: 72.6 versus 43.9 months, p = 0.045). Journal of Thoracic Oncology 2012 7, 76-84DOI: ( /JTO.0b013e318232b98a) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis "

Similar presentations

Frances A Shepherd, MD, Rafael Rosell, MD  Journal of Thoracic Oncology 

Frances A Shepherd, MD, Rafael Rosell, MD  Journal of Thoracic Oncology 
Naomi Fujioka, MD, Christopher A. French, MD, Michael J

Naomi Fujioka, MD, Christopher A. French, MD, Michael J
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 

Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Primary Mucoepidermoid Carcinoma of the Esophagus

Primary Mucoepidermoid Carcinoma of the Esophagus
Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer.

Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer.
WT1 Promotes Invasion of NSCLC via Suppression of CDH1

WT1 Promotes Invasion of NSCLC via Suppression of CDH1
RNAscope The Journal of Molecular Diagnostics

RNAscope The Journal of Molecular Diagnostics
Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in.

Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in.
Detection of Rearrangements and Transcriptional Up-Regulation of ALK in FFPE Lung Cancer Specimens Using a Novel, Sensitive, Quantitative Reverse Transcription.

Detection of Rearrangements and Transcriptional Up-Regulation of ALK in FFPE Lung Cancer Specimens Using a Novel, Sensitive, Quantitative Reverse Transcription.
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma  Daniel L. Albertus, BS, Christopher.

AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma  Daniel L. Albertus, BS, Christopher.
Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT  Zhen-Yu He, San-Gang Wu, Fang Peng,

Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT  Zhen-Yu He, San-Gang Wu, Fang Peng,
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma  Jun Wang, MD, PhD, Zhi Li, MD, PhD,

Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma  Jun Wang, MD, PhD, Zhi Li, MD, PhD,
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.

A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.
Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas  Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.

Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas  Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma

MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Treatment of Lung Cancer with an ALK Inhibitor After EML4-ALK Fusion Gene Detection Using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration 

Treatment of Lung Cancer with an ALK Inhibitor After EML4-ALK Fusion Gene Detection Using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration 

Similar presentations

Ads by Google